The innovations taking place in medical and health-care technology — known as ‘med-tech’ and ‘health-tech’ — involve ...
Nov. 8, 2024 — Prostate cancer is the second most common cancer in men worldwide. Researchers have investigated a new strategy for the development of treatment options that not only slow tumor ...
Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...
The majority of cases of lung cancers are diagnosed at later stages, meaning the disease can be harder to treat ...
Collaboration utilizes PeriNess' expertise in clinical development of human recombinant DNase and bolsters efforts towards clinical ...
Scientists have created a world-first urine test which could indicate the first possible signs of lung cancer.The majority of cases of lung cancer in England are diagnosed at later stages, meaning the ...
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast ...
If the cancer has only spread regionally (for example, to lymph nodes in the neck), the relative survival rate is 70 percent. If the cancer has not spread beyond the tongue, the five-year relative ...
Blood tests are used to check pregnancies for any health problems of either the mom or the fetus. The prenatal cell-free DNA ...
Tumour biomarkers is a term used to describe many different potential markers of cancer development and progression. These markers can come in many forms for example, proteins, biochemicals, ...
Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted ...
Image credit: Free Public Domain Illustrations by rawpixel ... and tumour suppressor genes involved in cancer development. The mid-20th century brought chemotherapy into the arsenal against ...